The kernicterus treatment global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Kernicterus Treatment Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size -
The
kernicterus treatment market size has grown steadily in recent years. It
will grow from $2.88 billion in 2023 to $2.98 billion in 2024 at a
compound annual growth rate (CAGR) of 3.4%. The growth in the historic
period can be attributed to improvements in neonatal care practices,
increased awareness among healthcare professionals, government
initiatives for maternal and child health, research funding and clinical
trials, collaborations in medical research..
The kernicterus treatment market size is expected to see steady growth in the next few years. It will grow to $3.29 billion in 2028 at a compound annual growth rate (CAGR) of 2.6%. The growth in the forecast period can be attributed to continuous medical education programs, global health policies and initiatives, patient advocacy and support groups, international collaboration in pediatric research, government funding for neonatal health.. Major trends in the forecast period include advancements in neonatal jaundice monitoring technologies, introduction of phototherapy devices with enhanced features, development of bilirubin-reducing medications, focus on home-based phototherapy solutions, implementation of bilirubin nomograms and guidelines, integration of telehealth for remote monitoring..
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report
Scope Of Kernicterus Treatment Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Kernicterus Treatment Market Overview
Market Drivers -
The
prevalence of neonatal jaundice is driving the growth of the
kernicterus treatment market going forward. Neonatal jaundice, also
known simply as jaundice in newborns, is a common and typically harmless
condition characterized by the yellowing of a baby's skin and the
whites of their eyes. Kernicterus treatment is commonly used for
neonatal jaundice; it manages the symptoms and provides supportive care.
This procedure removes blood from the baby and replaces it with blood
with a lower bilirubin level, improving the affected child's quality of
life. For instance, in August 2023, according to reports published by
the National Library of Medicine, a US-based biomedical library,
globally, about 1.1 million babies each year develop severe neonatal
hyperbilirubinemia (neonatal jaundice). Furthermore, in February 2021,
according to ClinMed International Library, a US-based publishing
company, it was estimated that at least 114,000 infants die yearly from
neonatal hyperbilirubinemia (neonatal jaundice). Therefore, the
prevalence of neonatal jaundice is expected to propel the growth of the
kernicterus treatment market.
Market Trends -
Major institutes
operating in the kernicterus treatment market are developing innovative
technological products, such as wearable devices to monitor jaundice
accurately, that help gain a competitive advantage. A wearable device is
a small, flexible patch placed on the body according to the treatment
requirement. For instance, in March 2021, Yokohama National University, a
Japan-based university, designed the first-ever wearable device to
accurately monitor jaundice, a yellowing of the skin due to increased
bilirubin levels in the blood that can result in severe medical
conditions in infants. This wearable sensor for infants can constantly
measure bilirubin to achieve the intricate balance of administering the
accurate amount of blue light required to neutralize the correct
bilirubin levels. Moreover, it is a small, flexible patch that is placed
on the infant's chest, and it transmits data to a smartphone or
computer, where doctors or parents can monitor it. Also, it is more
accurate and convenient than traditional methods of monitoring jaundice,
such as blood tests.
The kernicterus treatment market covered in this report is segmented –
1) By Treatment: Phototherapy, Intravenous Immunoglobulins (IVIG), Blood Transfusion, Medication, Other Treatments
2)
By Symptoms: Jaundice, Unusual Eye Movements, Vomiting, Fever, Poor
Feeding, Apnoea, Irritability, Seizures, Sleepiness, Other Symptoms
3) By Dosage: Injection, Solution, Other Dosages
4) By End-Users: Clinic, Hospital, Other End-Users
Get an inside scoop of the kernicterus treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13470&type=smp
Regional Insights -
North
America was the largest region in the kernicterus treatment market in
2023. The regions covered in the kernicterus treatment market report are
Asia-Pacific, Western Europe, Eastern Europe, North America, South
America, Middle East, Africa.
Key Companies -
Major companies
operating in the kernicterus treatment market report are Pfizer Inc., F.
Hoffmann-La Roche Ltd , Merck and Co. Inc., AbbVie Inc., Bayer AG,
Novartis AG, AstraZeneca plc., Abbott Laboratories, Sanofi SA,
GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Johnson and
Johnson Private Limited, Baxter International Inc., Grifols S.A, Sun
Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Alembic
Pharmaceuticals Limited, Lupin Pharmaceuticals Inc., CSL Limited,
Glenmark Pharmaceuticals Ltd., Cipla Inc., Torrent Pharmaceuticals Ltd.,
Octapharma Brasil Ltda, Kedrion S.p.A, Biotest AG, Wockhardt Ltd.,
Mylan N.V., Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd.,
China Biologic Products Holdings Inc.
Table of Contents
1. Executive Summary
2. Kernicterus Treatment Market Report Structure
3. Kernicterus Treatment Market Trends And Strategies
4. Kernicterus Treatment Market – Macro Economic Scenario
5. Kernicterus Treatment Market Size And Growth
…..
27. Kernicterus Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment